- Home
- INGR vs HALO Comparison
INGR vs HALO Comparison
Compare INGR & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INGR
- HALO
- Stock Information
- Founded
- INGR 1906
- HALO 1998
- Country
- INGR United States
- HALO United States
- Employees
- INGR N/A
- HALO N/A
- Industry
- INGR Packaged Foods
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INGR Consumer Staples
- HALO Health Care
- Exchange
- INGR Nasdaq
- HALO Nasdaq
- Market Cap
- INGR 8.4B
- HALO 7.4B
- IPO Year
- INGR 1997
- HALO N/A
- Fundamental
- Price
- INGR $140.83
- HALO $52.02
- Analyst Decision
- INGR Hold
- HALO Buy
- Analyst Count
- INGR 5
- HALO 9
- Target Price
- INGR $150.20
- HALO $63.56
- AVG Volume (30 Days)
- INGR 439.6K
- HALO 3.1M
- Earning Date
- INGR 05-06-2025
- HALO 05-06-2025
- Dividend Yield
- INGR 2.27%
- HALO N/A
- EPS Growth
- INGR N/A
- HALO 55.40
- EPS
- INGR 9.47
- HALO 3.76
- Revenue
- INGR $7,361,000,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- INGR $3.18
- HALO $24.79
- Revenue Next Year
- INGR $2.60
- HALO $22.65
- P/E Ratio
- INGR $14.90
- HALO $13.83
- Revenue Growth
- INGR N/A
- HALO 25.64
- 52 Week Low
- INGR $111.54
- HALO $41.28
- 52 Week High
- INGR $155.44
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- INGR 64.91
- HALO 39.78
- Support Level
- INGR $135.00
- HALO $47.50
- Resistance Level
- INGR $138.74
- HALO $69.94
- Average True Range (ATR)
- INGR 2.82
- HALO 3.52
- MACD
- INGR 0.63
- HALO -1.49
- Stochastic Oscillator
- INGR 95.47
- HALO 19.64
About INGR Ingredion Incorporated
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.